Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2012 by University of Cincinnati
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Olivier Rixe, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT01508117
First received: January 6, 2012
Last updated: January 10, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)